首页> 外文OA文献 >Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges

【2h】

Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges

机译：长效兴奋剂，用于治疗注意力缺陷/多动障碍：重点关注缓释制剂和前药赖氨苯丙胺二甲磺酸酯，以应对持续的临床挑战

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Long-acting stimulants for treatment of attention-deficit/ hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges [J] . Frank A. Lopez, Jacques R. Leroux Attention deficit and hyperactivity disorders . 2013,第3期

机译：长效兴奋剂，用于治疗注意力缺乏症/多动症：专注于缓释制剂和前药赖氨苯丙胺二甲磺酸酯以应对持续的临床挑战
2. Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges [J] . Frank A. López, Jacques R. Leroux ADHD Attention Deficit and Hyperactivity Disorders . 2013,第3期

机译：长效兴奋剂，用于治疗注意力不足/多动障碍：重点关注缓释制剂和前药赖氨苯丙胺二甲磺酸酯，以应对持续的临床挑战
3. Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder. [J] . Faraone SV Expert opinion on pharmacotherapy . 2008,第9期

机译：Lisdexamfetamine dimesylate：用于注意缺陷/多动障碍的首个长效前药兴奋剂治疗。
4. Effectiveness of methylphenidate and combined treatment (methylphenidate and psychosocial treatment) for Chinese children with attention-deficit/hyperactivity disorder in a community mental health center. [D] . So, Yuk-chi. 2005

机译：哌醋甲酯和联合治疗（哌醋甲酯和社会心理治疗）对中国社区精神卫生中心注意力不足/多动障碍儿童的有效性。
5. Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges [O] . Frank A. López, Jacques R. Leroux -1

机译：长效兴奋剂用于治疗注意力缺陷/多动障碍：重点关注缓释制剂和前药赖氨苯丙胺二甲磺酸酯以应对持续的临床挑战
6. PMH32 Cost-effectiveness of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant versus long-acting stimulant monotherapy for the treatment of attention-deficit/hyperactivity disorder in Canada [O] . Lachaine J., Sikirica V., Mathurin K. 2014

机译：PMH32胍法辛缓释作为长效兴奋剂与长效兴奋剂单一疗法的辅助疗法在加拿大治疗注意力不足/多动障碍的成本效益

Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges

著录项

引文网络

相似文献

相关主题

期刊订阅